Kura Oncology, Inc. announced the appointment of Marc Grasso, M.D., as Chief Financial Officer and Chief Business Officer, effective August 21, 2018. Dr. Grasso succeeds Heidi Henson, who served as Kura's Chief Financial Officer since the company's inception in August 2014. Dr. Grasso joins Kura from Stifel, where he was Managing Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.77 USD | -1.98% | -3.35% | +44.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.44% | 1.58B | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+1.69% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology, Inc. Announces Executive Changes